Linola Fett

Unsaturated fatty acids (C18:2), the active ingredient in Linola Fett, is a fatty acid presented as a topical preparation for skin application. It is used to support the skin barrier and alleviate dryness in various dermatological conditions.

GNH USA supplies Linola Fett as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Linola Fett, a topical fatty‑acid preparation, is applied to skin conditions that benefit from barrier support and moisturisation. - Atopic dermatitis: helps reduce dryness and improve skin barrier function. - Xerosis (dry skin): restores moisture and alleviates scaling. - Minor irritant dermatitis: soothes inflammation and supports healing.

Topical application of Linola Fett may be associated with local skin reactions.

Common Side Effects: - Mild erythema: transient redness at the application site. - Pruritus: occasional itching. - Burning sensation: brief discomfort during initial use. - Dryness: paradoxical dryness if over‑applied. - Contact dermatitis: allergic response to formulation components.

Serious or Rare Side Effects: - Severe allergic reaction: swelling, hives, or difficulty breathing. - Persistent ulceration: non‑healing skin breakdown. - Secondary infection: bacterial or fungal overgrowth at irritated sites. - Systemic absorption effects: unlikely but reported in extensive damaged skin.

Before using Linola Fett, consider the following safety measures. - Contraindication: Do not apply to broken or infected skin without medical advice. - Allergy screening: Verify no known hypersensitivity to fatty acids or excipients. - Pediatric use: Use only under supervision of a healthcare professional. - Pregnancy and lactation: Consult a physician before use. - Interaction with occlusive dressings: Avoid covering treated area unless directed. - Store below 25°C: keep in the original container, protect from moisture and direct sunlight.

Linola Fett may interact with other topical agents or systemic conditions.

Major Interactions (Avoid): - Concurrent use of potent topical corticosteroids: may mask irritation and delay detection of adverse reactions. - Occlusive dressings over treated area: can increase absorption and risk of irritation.

Moderate Interactions (Monitor Closely): - Other emollients containing similar fatty acids: may cause cumulative skin sensitisation. - Systemic lipid‑lowering therapy: no direct interaction, but monitor skin response. - Phototherapy: assess for increased photosensitivity when combined.